Extracted from MDA231 breast cancer cells, breast tumor sample with nuclear staining of hRad9 (A) and a control tumor sample with no nuclear staining (B)

The relative position for molecular weights (in KDa) are indicated on the right. Protein extracts were treated with λ phosphatase (100 and 500 units respectively).<p><b>Copyright information:</b></p><p>Taken from "Localization of hRad9 in breast cancer"</p><p>http://www.biomedcentral.com/1471-2407/8/196</p><p>BMC Cancer 2008;8():196-196.</p><p>Published online 11 Jul 2008</p><p>PMCID:PMC2483722.</p><p></p